The Personalized Medicine Coalition has awarded Leroy Hood, president and co-founder of the Institute for Systems Biology, its 2011 Leadership in Personalized Medicine Award. The PMC recognized Hood for his "pioneering vision to transform medicine from reactive to predictive, preventive, personalized and participatory (P4 medicine)."
Hood and his colleagues helped developed the DNA and sequencers that were instrumental in mapping the human genome. He has also helped found 14 biotechnology companies and has published more than 700 peer-reviewed articles.
CollabRx has appointed James Karis as its new CEO. Jay Tenenbaum, company founder and former CEO, will remain as chairman of the board.
Karis most recently served as president and CEO of biosimulation firm Entelos. Prior to that, he was president and chief operating officer of Parexel International and COO of Pharmaco International. He has also held management positions at Baxter International and KMR Group.
Karis holds an MA in economics from American University and a BS in industrial management and economics from Purdue University.
23andMe has appointed Ruben Mesa as scientific advisor of its myeloproliferative neoplasms research project advisory board.
Mesa is a professor of medicine and chair of the division of hematology and medical oncology at the Mayo Clinic.
He holds a BS in nuclear engineering and physiology from the University of Illinois at Urbana-Champaign and an MD from the Mayo Clinic.